Arnela Saljic

Arnela Saljic

Research assistant, Postdoc

Member of:


    Publication year:
    All
    1 - 10 out of 32Page size: 10
    Sort by: 1st author
    1. Published

      Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation

      Song, J., Navarro-Garcia, J. A., Wu, J., Saljic, Arnela, Abu-Taha, I., Li, L., Lahiri, S. K., Keefe, J. A., Aguilar-Sanchez, Y., Moore, O. M., Yuan, Y., Wang, X., Kamler, M., Mitch, W. E., Ruiz-Hurtado, G., Hu, Z., Thomas, S. S., Dobrev, D., Wehrens, X. H. & Li, N., 2023, In: The Journal of Clinical Investigation. 133, 19

      Research output: Contribution to journal › Journal article › Research › peer-review

    2. Published

      NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias

      Scott, L., Fender, A. C., Saljic, Arnela, Li, L., Chen, X., Wang, X., Dr Linz, Dominik Karl, Lang, J., Hohl, M., Twomey, D., Pham, T. T., Diaz-Lankenau, R., Chelu, M. G., Kamler, M., Entman, M. L., Taffet, G. E., Sanders, P., Dobrev, D. & Li, N., 2021, In: Cardiovascular Research. 117, 7, p. 1746-1759

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      P2X7 receptors: central drivers of the neurocardiac link between atrial fibrillation and depression?

      Saljic, Arnela & Heijman, J., 2024, In: Europace. 26, 2, 3 p., euae023.

      Research output: Contribution to journal › Editorial › Research › peer-review

    4. Published

      In vivo knockdown of SK3 channels using antisense oligonucleotides protects against atrial fibrillation in rats

      Saljic, Arnela, Soattin, Luca, Trachsel, D. S., Boddum, K. & Jespersen, Thomas, Oct 2020, In: Journal of Molecular and Cellular Cardiology. 147, p. 18-26

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Recent Advances in Antiarrhythmic Drug Therapy

      Saljic, Arnela, Heijman, J. & Dobrev, D., 2023, In: Drugs. 83, 13, p. 1147 - 1160 14 p.

      Research output: Contribution to journal › Review › Research › peer-review

    6. Published

      TGF-β1-induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?

      Saljic, Arnela, Grandi, E. & Dobrev, D., 2022, In: The Journal of Clinical Investigation. 132, 13, 4 p., e161070.

      Research output: Contribution to journal › Letter › Research › peer-review

    7. Published

      Botulinum toxin for prevention of post-operative atrial fibrillation

      Saljic, Arnela, Hansen, M. E. H. & Dobrev, D., 2023, In: Naunyn-Schmiedeberg's Archives of Pharmacology. 396, 3, p. 385-388

      Research output: Contribution to journal › Editorial › Research › peer-review

    8. Published

      Anti-arrhythmic investigations in large animal models of atrial fibrillation

      Saljic, Arnela, Jespersen, Thomas & Buhl, Rikke, 2022, In: British Journal of Pharmacology. 179, 5, p. 838-858

      Research output: Contribution to journal › Review › Research › peer-review

    9. Published

      Emerging Antiarrhythmic Drugs for Atrial Fibrillation

      Saljic, Arnela, Heijman, J. & Dobrev, D., 2022, In: International Journal of Molecular Sciences. 23, 8, p. 1-32 4096.

      Research output: Contribution to journal › Review › Research › peer-review

    10. Published

      The impact of an atrial septal defect on the progression of atrial tachypacing-induced atrial fibrillation in a Danish Landrace pig: A case report

      Saljic, Arnela, Hertel, Julie Norup, Leonhardt, C., Nissen, Sarah Dalgas, Dobrev, D., Jepps, Thomas Andrew Qvistgaard, Jespersen, Thomas & Sattler, Stefan M, 2022, In: IJC Heart and Vasculature. 40, 3 p., 101054.

      Research output: Contribution to journal › Letter › Research › peer-review

    Previous 1 2 3 4 Next

    ID: 170618029